Articular cartilage injuries represent a significant clinical challenge due to the tissue’s limited intrinsic healing capacity. Over the past decade, tissue engineering has emerged as a promising strategy for cartilage repair, relying on biocompatible scaffolds that provide structural support and guide cell behavior. A critical determinant of scaffold success is its surface properties, as they directly influence the initial attachment, proliferation, and differentiation of chondrocytes (cartilage cells). Recent innovations in scaffold surface modification have dramatically improved cell adhesion, thereby enhancing the overall efficacy of cartilage regeneration. This article reviews the importance of surface engineering, explores cutting-edge modification techniques, and discusses their impact on clinical outcomes.

Importance of Scaffold Surface Modification

Scaffolds serve as temporary extracellular matrices (ECMs) that facilitate cell infiltration, nutrient diffusion, and tissue formation. For cartilage repair, the scaffold must first promote robust chondrocyte adhesion. Adhesion is mediated by integrins—transmembrane receptors that bind to specific ECM proteins such as collagen type II, fibronectin, and laminin. Surface modification at the nanoscale can mimic these natural binding sites, triggering intracellular signaling cascades that regulate cell survival, migration, and matrix synthesis.

Key surface properties influencing adhesion include:

  • Surface roughness – Nanoscale roughness increases the surface area available for integrin clustering, enhancing focal adhesion formation.
  • Hydrophilicity – Hydrophilic surfaces promote protein adsorption from the surrounding medium, creating a bioactive layer that facilitates cell attachment.
  • Surface charge – Positively charged surfaces (e.g., amine groups) can electrostatically attract negatively charged cell membranes, improving initial adhesion.
  • Chemical functionality – Specific functional groups (e.g., carboxyl, hydroxyl) can be used to covalently immobilize adhesion peptides or growth factors.

Without adequate surface modification, synthetic scaffolds often elicit a foreign-body response or fail to integrate with native tissue, leading to poor clinical outcomes. Therefore, tailoring surface properties is essential for achieving functional cartilage regeneration.

Recent Innovations in Surface Modification Techniques

A wide array of physical, chemical, and biological approaches has been developed to engineer scaffold surfaces that promote chondrocyte adhesion. Below, we detail the most promising innovations, supported by recent research.

Nanostructuring

Creating nanoscale topographies on scaffold surfaces replicates the hierarchical organization of native ECM. Techniques such as electrospinning, phase separation, and lithography produce fibers or pores with diameters ranging from 10–500 nm. For example, electrospun polycaprolactone (PCL) nanofibers modified with surface etching exhibit significantly higher chondrocyte attachment compared to smooth films. Studies have shown that nanogrooves and nanopits guide cell alignment, while nanopillars can increase integrin clustering by up to 200%. A landmark paper in Biomaterials demonstrated that poly(lactic-co-glycolic acid) (PLGA) scaffolds with nanotopographical features promoted chondrocyte proliferation and glycosaminoglycan (GAG) deposition (Smith et al., 2014).

Bioactive Coatings

Coating scaffold surfaces with native ECM components or synthetic peptides provides direct biochemical cues to chondrocytes. Common coatings include:

  • Collagen type I/II – Improves integrin binding and stimulates collagen II synthesis.
  • Hyaluronic acid (HA) – Binds to CD44 receptors on chondrocytes, enhancing cell migration and phenotype maintenance.
  • Fibronectin-derived peptides (e.g., RGD) – RGD sequences are widely used to enhance adhesion via α5β1 integrins. Immobilizing RGD gradients on scaffolds has been shown to direct chondrocyte spreading.
  • Chondroitin sulfate – Sulfated GAGs attract growth factors and support cell–matrix interactions.

Recent innovations include layer-by-layer (LbL) assembly of HA and collagen to create controlled release coatings. In a study by Acta Biomaterialia, LbL-coated PLGA scaffolds showed a 3-fold increase in chondrocyte adhesion and sustained ECM production over 21 days (Zhang et al., 2016).

Surface Patterning

Micro- and nanoscale patterning guides cell orientation and improves adhesion strength. Techniques like photolithography, microcontact printing, and laser ablation create defined patterns of adhesive islands or grooves. For example, micropatterned polydimethylsiloxane (PDMS) substrates with parallel grooves (width 10–50 μm) align chondrocytes and increase collagen II expression. Nanoscale posts (e.g., 200 nm diameter) have been used to study mechanotransduction; cells on taller posts exert higher traction forces and form stronger adhesions. A review in Advanced Healthcare Materials highlighted that surface patterning can direct stem cell differentiation toward chondrogenic lineages, further expanding its utility (Kim et al., 2021).

Chemical Functionalization

Introducing specific chemical groups onto scaffold surfaces enhances hydrophilicity and provides reactive sites for biomolecule immobilization. Common methods include:

  • Plasma polymerization – Depositing thin films of amine, carboxyl, or hydroxyl groups using glow discharge.
  • Silane chemistry – Applying silanes to introduce functional groups (e.g., –NH₂, –COOH) on glass or metal oxide surfaces.
  • Click chemistry – Copper-catalyzed azide-alkyne cycloaddition enables precise immobilization of peptides or proteins under mild conditions.
  • Polyelectrolyte multilayers – Alternating deposition of charged polymers creates functionalized surfaces with tunable roughness and charge density.

Functionalized surfaces can also be designed to release anti-inflammatory molecules (e.g., ibuprofen) in response to pH changes, addressing the inflammatory environment of osteoarthritic joints. For instance, polyethylene glycol (PEG) hydrogels with pendant carboxyl groups were conjugated with transforming growth factor-β1 (TGF-β1) to enhance chondrogenesis; results showed a 50% increase in aggrecan synthesis compared to non-functionalized controls.

Plasma Treatment

Non-thermal plasma treatment is a versatile, solvent-free method to modify surface energy and introduce reactive species. Oxygen plasma increases surface oxygen content, creating hydroxyl and carboxyl groups that improve wettability. Argon plasma can etch the surface, increasing roughness without changing chemistry. A study in Plasma Processes and Polymers treated PCL scaffolds with atmospheric-pressure plasma, resulting in a contact angle reduction from 120° to 30° and a 4-fold increase in chondrocyte adhesion density (Lee et al., 2022). Furthermore, plasma polymerization can deposit functional coatings in a single step, allowing for combination with other techniques like electrospinning.

Emerging Hybrid Approaches

Combining multiple modification strategies often yields synergistic effects. For example, nanostructured scaffolds can be coated with bioactive molecules and then treated with plasma to enhance protein immobilization. Three-dimensional (3D) bioprinting now allows precise deposition of cell-laden hydrogels with spatially controlled surface chemistry. A recent innovation involves embedding magnetic nanoparticles within scaffolds; applying an external magnetic field modifies the surface topography in real time, influencing cell adhesion dynamics.

Impact on Cartilage Regeneration

Enhanced surface modifications have led to measurable improvements in cartilage repair outcomes, as evidenced by both in vitro and in vivo studies.

Improved Cell Adhesion and Proliferation

Modified scaffolds consistently show higher chondrocyte attachment rates (often >80% within 4 hours) compared to unmodified controls (<30%). Proliferation rates, as measured by DNA content or MTT assays, increase by 2–5 fold over 7–14 days. For example, nanostructured and RGD-functionalized PCL scaffolds doubled the cell number after 10 days of culture.

Enhanced Extracellular Matrix Production

Surface modifications stimulate chondrocytes to secrete a cartilage-specific ECM rich in collagen type II and sulfated GAGs. Biochemical assays indicate that GAG content per cell can increase by up to 60% on optimized surfaces. Histological staining (Safranin O, Alcian blue) shows dense, uniform matrix deposition throughout the scaffold.

Mechanical Property Restoration

With improved ECM accumulation, the mechanical properties of the engineered tissue approach those of native cartilage. Compressive modulus values of 0.5–1.5 MPa have been reported for modified scaffolds after 6 weeks of culture, compared to 0.2–0.5 MPa for unmodified versions. These mechanical improvements are critical for load-bearing applications.

Preclinical and Clinical Evidence

Animal models, including rabbit and sheep osteochondral defects, demonstrate that surface-modified scaffolds achieve superior integration and tissue morphology at 12 weeks. Histology reveals hyaline-like cartilage formation with proper zonal organization. A pilot clinical study using plasma-treated polyurethane scaffolds reported pain reduction and improved knee function scores (IKDC, KOOS) in patients with focal cartilage defects. Although larger trials are needed, these results underscore the translational potential of surface modification.

Future Directions

Despite significant progress, several challenges remain. Future efforts are focused on:

  • Smart and responsive surfaces – Scaffolds that change surface properties in response to pH, temperature, or enzymatic activity could regulate cell adhesion temporally. For example, thermoresponsive polymers (e.g., poly(N-isopropylacrylamide)) allow cell detachment and controlled release.
  • Dual-function coatings – Integrating adhesion peptides with growth factor delivery (e.g., TGF-β, BMP-7) can simultaneously enhance attachment and differentiation. Recent constructs combine RGD and heparin-binding domains to sequester heparin-binding growth factors in situ.
  • Immune modulation – Modifying surfaces to promote an anti-inflammatory macrophage phenotype (M2) while suppressing M1 activation may improve long-term implant acceptance. Coating with interleukin-4 or dexamethasone is being explored.
  • Personalized scaffolds – Using patient-specific imaging (MRI, CT) and 3D printing to create defect-matching scaffolds with customized surface patterns. Bioprinting with patient-derived cells and tuned surface chemistry could eliminate donor-site morbidity.
  • Advanced characterization – Techniques like atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS) will enable nanoscale mapping of surface chemistry and topography, guiding rational design.
  • Scale-up and translation – Developing cost-effective, reproducible surface modification methods (e.g., roll-to-roll plasma treatment) suitable for Good Manufacturing Practice (GMP) is essential for clinical adoption.

Looking ahead, the convergence of surface engineering with biofabrication and regenerative medicine holds immense promise. As reviewed by Nature Reviews Materials, the next generation of scaffolds will likely incorporate dynamic surface cues that adapt to the healing environment, ultimately achieving full-thickness cartilage repair (Huang et al., 2022).

In summary, innovations in scaffold surface modification have already transformed cartilage tissue engineering. From nanostructuring and bioactive coatings to plasma treatment and chemical functionalization, each technique offers unique advantages. The resulting improvements in chondrocyte adhesion, proliferation, and matrix deposition bring us closer to reliable, off-the-shelf solutions for cartilage injuries. Continued interdisciplinary collaboration between materials scientists, biologists, and clinicians will drive this field forward.